Clinical Trial

Laplace Early Feasibility Study - Canada

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to assess the safety and technical feasibility of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-05.
Trial Details
NCT Number NCT07171060
Lead Sponsor Laplace Interventional, Inc
Conditions Tricuspid Regurgitation
Enrollment 15 participants
Start Date 2024-06-18
Primary Completion 2027-12-30 (estimated)
Study Completion 2032-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-22